placeholder image

C. M. Lockhart All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Patient characteristics and use for bevacizumab in ophthalmology and oncology in a distributed research network. 
    Journal of managed care & specialty pharmacy. 2025
  • Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States. 
  • Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithm. 
    Journal of Medical Economics. 2023
  • BBCIC Research Network analysis of first-cycle prophylactic G-CSF use in patients treated with high-neutropenia risk chemotherapy. 
  • Patient characteristics and utilization patterns of short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilars compared to their reference product. 

    • Contact

    full name

  • C. M. Lockhart

    • Quick Info

    Publications

    Collaboration